Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Principal, Venture Investments, JJDC
Vijay is a Principal with JJDC and is based in Johnson & Johnson’s California Innovation Center. He focuses on equity investments in biopharmaceutical companies.
Prior to joining JJDC, Vijay was a Director of Ventures & Early-Stage Collaborations at AbbVie, where he led venture investments and early-stage business development transactions. Prior to AbbVie, Vijay was co-founder and CEO of an innovative peptide manufacturing company, and an independent consultant to several top-tier life sciences venture capital firms and biopharmaceutical companies. Previously, Vijay led business development at Enlight Biosciences, a seed-stage venture creation firm founded by PureTech Health and partnered with 7 major pharmaceutical companies. He started his business career as a strategy consultant at the Boston Consulting Group (BCG).
Vijay earned an AM and a PhD in bioorganic chemistry from Harvard University, and a BS in chemistry with highest honors and highest distinction from the University of North Carolina at Chapel Hill.